This story demonstrates the success that Berkley Edge can have in helping control high-dollar claims.
Read our March 2024 update on the cell and gene therapy pipeline, with an in-depth look at Casgevy
U.S. employees are facing new challenges while on the road, according to a new survey sponsored by Berkley Accident and Health.
This case study shows the benefits of having an independent Stop Loss carrier focused on the right care at the right price.
Read our October 2023 report on the cell and gene therapy market
Read our April 2023 report on the cell and gene therapy market
Berkley Accident and Health shows the benefits of having a Provider Excess insurer that not only assists clients with high-dollar claims, but also focuses on the right care at the right price.
Berkley Accident and Health is committed to helping our policyholders offer affordable, high-quality health benefits. One of the tangible ways we do that is through our Berkley Edge program. Recently, our Berkley Edge team was conducting a routine review for our policyholder, a well-known west coast symphony orchestra, when they came across the claim for Read More